Celldex Therapeutics (CLDX) Posts Q2 Loss of 24c/Share

August 6, 2013 8:06 AM

Celldex Therapeutics (NASDAQ: CLDX) reported Q2 EPS of ($0.24), $0.02 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found